Navigation Links
PTC Therapeutics Completes Enrollment of Phase 3 Trial of Ataluren in Patients with Cystic Fibrosis
Date:12/21/2010

SOUTH PLAINFIELD, N.J., Dec. 21, 2010 /PRNewswire/ -- PTC Therapeutics, Inc. announced today that it has completed enrollment of a Phase 3 clinical trial of ataluren, an investigational new drug, in patients with nonsense mutation cystic fibrosis (nmCF).

(Logo: http://photos.prnewswire.com/prnh/20010919/PTCLOGO)

The 48-week study is designed to determine whether ataluren can improve lung function in patients with nmCF.  The trial has enrolled 238 patients at 36 sites in North America, Europe and Israel.  Patients who complete the treatment phase of the Phase 3 trial are eligible to participate in a 48-week, open-label extension study, which has begun enrolling patients.

"The enrollment of this trial represents an important step forward in our efforts to develop disease-modifying treatments that advance the standard of care in CF and improve quality of life for CF patients," stated Michael Konstan, MD, Chairman, Department of Pediatrics at Rainbow Babies and Children's Hospital in Cleveland, Ohio.  Dr. Eitan Kerem, Head, Department of Pediatrics and CF Center, Hadasash University Hospital, Jerusalem, Israel added, "Despite significant advances in the 21 years since the identification of the disease-causing gene, cystic fibrosis remains a debilitating and life-threatening disorder and available therapies focus only on alleviating symptoms. Ataluren couples a patient's genetic diagnosis with a mutation-specific therapeutic approach designed to address the underlying cause of the disease."

Ataluren is a protein restoration therapy designed to enable the formation of full-length, functional cystic fibrosis transmembrane regulator (CFTR) protein in patients with cystic fibrosis due to a nonsense mutation.  CFTR is a critical protein lacking in CF patients.  Nonsense mutations are categorized as Class I mutations that result in little or no production of the CFTR protein.  CF patients with Class I mutations typi
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013 iHealth Lab Inc., a pioneer ... healthcare products and a powerful integrated mobile app ... of two new fitness products to its existing ... the Wireless Pulse Oximeter and Wireless Activity and ... iHealth Lab is also excited ...
(Date:5/21/2013)... , May 21, 2013  Lehigh Valley Health Network ... TM devices, adding to its existing arsenal of ... taking up residence within the network, LVHN is now ... to proactively combat superbugs and provide the best possible ... Room Ultraviolet Disinfector, TRU-D – the signature product of ...
(Date:5/21/2013)... 21, 2013  Healthcare organizations expanding into emerging markets ... , India and ... no shortcuts.  This is proving particularly challenging, considering the ... must change the dialogue around BRIC, as it is ... and building regional partnerships to build a sustainable business. ...
Breaking Medicine Technology:iHealth Lab adds new products and partners to mobile personal healthcare offering 2iHealth Lab adds new products and partners to mobile personal healthcare offering 3Lehigh Valley Expands Fleet of Superbug-Slaying Robots 2Lehigh Valley Expands Fleet of Superbug-Slaying Robots 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 2Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 4
... Va., Aug. 30, 2011 Star Scientific, Inc. (NASDAQ: ... is pleased to initiate the launch today of Anatabloc™, ... immune system in maintaining healthy levels of inflammation.  Anatabloc™, ... being launched via a dedicated website ( www.anatabloc.com ) ...
... 2011 Bench International, a global, milestone-based, performance-driven ... sciences industry, recently opened new offices in Geneva ... strategy. The offices are strategically placed to serve ... aligned with Bench,s European headquarters in London to ...
Cached Medicine Technology:Star Scientific Launches Anatabloc™ Dietary Supplement 2Star Scientific Launches Anatabloc™ Dietary Supplement 3Star Scientific Launches Anatabloc™ Dietary Supplement 4Star Scientific Launches Anatabloc™ Dietary Supplement 5Bench International Expands Presence in Europe with Opening of Offices in Switzerland 2
(Date:5/21/2013)... 21, 2013 Representatives with Hammerhead Bicycles announced ... success that the company has achieved its overall goal of ... one was to move Hammerhead Bicycles from a house brand ... Scott Robertson. , Robertson explained that the bike shop will ... exclusively focus on all things 29er and 650b. ...
(Date:5/21/2013)... MAY 21, 2013 Three major Ohio universities and ... Foundation to establish a new collaborative research program aimed ... The March of Dimes intends to invest $10 million ... March of Dimes Prematurity Research Center -- Ohio Collaborative ... Howse, President of the March of Dimes. "This new ...
(Date:5/21/2013)... Atlanta, GA (PRWEB) May 21, 2013 ... Care, ScripNet and Procura Management, today announced that ... Award at Catamaran’s client advisory meeting. Conferred ... has partnered with Catamaran to create cutting edge ... This year, Healthcare Solutions was recognized for its ...
(Date:5/21/2013)... 2013 A plastic surgery Internet ... plastic surgery SEO services following an Internet survey. ... name the “Best Plastic Surgery SEO Services”. , ... was predictable. Well-known in the plastic surgery Internet ... than any other selection based on superior client ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Nearly 40 ... out of an award trip in Los Cabos, Mexico, Feb. ... “day house” for the elderly. , The facility serves meals ... of San Jose del Cabo, Mexico. , Platinum Vice President, ... while reflecting on the company’s history. , “Platinum got its ...
Breaking Medicine News(10 mins):Health News:Hammerhead Bicycles Now a Standalone Brand 2Health News:New multi-million dollar research center aims to solve the mystery of premature birth 2Health News:New multi-million dollar research center aims to solve the mystery of premature birth 3Health News:Healthcare Solutions Receives Innovation Award From Catamaran 2Health News:JD Media Surge's CosmeticSurgeonsOnline.com Voted #1 Source for Plastic Surgery SEO 2Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 2Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 3
... preventable, treatable diseases around,the world, Statement by ... TOYAKO, Japan, July 8 "The worldwide,pharmaceutical ... and,the Drugs for Neglected Diseases initiative (DNDi) in ... neglected diseases as a global health threat,and a ...
... 8 An economist examining the,proposed merger of ... the combined companies would have a market share ... to testimony presented to the,Pennsylvania Insurance Department today ... of CRA International, the proposed merger,would result in ...
... disorder is one of the most complex and challenging ... associated with considerable acute and longterm treatment needs and ... times of tremendous social burden for both the individual ... episodic, yet lifelong and clinically severe mood disorder. The ...
... tendon rupture, agency says , , TUESDAY, July 8 (HealthDay ... carry a black box warning alerting physicians to the ... their use, the U.S. Food and Drug Administration said ... 60; in kidney, heart and lung transplant recipients; and ...
... At 12:00 noon on July 8, 2008, J.,Douglas ... P.C.,filed the first drug product liability action in ... former Governor Engler,s grant of immunity,to drug manufacturers., ... was filed in the United,States District Court, Eastern ...
... the most important single factor predisposing to suicide, ... suicide are known to have suffered from depression. ... even after a suicide attempt. Antidepressive drugs represent ... their role has become somewhat controversial over the ...
Cached Medicine News:Health News:Global Health Progress Joins WHO and DNDi to Call For Increased Commitments to Fighting Neglected Tropical Diseases 2Health News:Economist Finds Highmark/IBC Merger Would Result in 70 Percent Share in Pennsylvania, Far Higher Than Initial Reports 2Health News:The ECNP consensus statement on bipolar depression 2Health News:FDA Mandates Black Box Warning for Some Antibiotics 2Health News:National Class Action Filed Against Manufacturer of Digitek(R) (Prescription Drug) in Federal Court in Michigan 2
Hudson Drill hand drill....
Hudson Downs hand drill....
Hudson Brace, snap lock chuck....
Sighting and visualization system of the digital operating suite. The platform that links navigation, and intra-operative imaging to form the ultimate surgical workstation....
Medicine Products: